GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR5A, IDO1, IGF1R, KDR, MPO, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
11.7748 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, IDO1, IGF1R, MPO, PPARA, PRKCB, PRKCD, PRKCE, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
11.725 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, IDO1, IGF1R, KDR, MPO, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TOP1, TRPV1, TYR |
11.3296 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MAOA, MET, MTNR1B, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1, XDH |
11.3296 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, IDO1, MPO, PRKCE, PTGES, PTGS2, RORC, SRC, TYR |
10.768 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, PRKCE, PRKCG, PTGES, PTGS2, RORC, SRC, TRPV1, TYR |
10.7477 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
10.0948 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
10.0772 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B |
9.9676 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, KDR, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TOP1, TRPV1 |
9.88178 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGES, PTGS2, TBXAS1, TRPV1 |
9.68405 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1 |
9.57959 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IDO1, IGF1R, KDR, MET, MMP12, MTNR1A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
8.36061 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IDO1, IGF1R, KDR, MMP12, PIM1, PRKCA, PTGES, PTGS2, SRC, XDH |
8.16389 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, PRKCE, SRC, TRPV1 |
8.16389 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
8.15401 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, MTNR1B, PRKCA, PRKCE |
8.15401 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, MTNR1A, MTNR1B, PPARA, PRKCG, RORC, SRC, TOP1 |
7.67262 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KCNA3, KDR, MET, MMP12, MTNR1B, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
7.64358 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOA, MPO, NQO2, PTGS2, TBXAS1, TYR, XDH |
7.55733 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
7.55733 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.50805 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.44269 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.37811 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IDO1, IGF1R, MET, MMP12, MPO, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SRC, TNKS2, TOP1, TRPV1, TYR |
7.34935 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IDO1, IGF1R, KDR, MAOA, MET, MMP12, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
7.28703 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS2, TBXAS1 |
7.27558 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.27219 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TRPV1 |
7.22521 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, GBA2, HTR2B, IDO1, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR, XDH |
7.12483 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, ESR1, HTR2A, HTR2B |
7.06826 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP1 |
7.05543 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IDO1, IGF1R, KDR, MET, MMP12, MTNR1A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.98593 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.98204 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
6.93173 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IDO1, IGF1R, KDR, MET, MPO, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
6.92926 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IDO1, IGF1R, KDR, MET, MPO, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
6.92799 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IDO1, IGF1R, KDR, MMP12, MPO, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TOP1, TRPV1, TYR |
6.84926 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
6.82823 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IDO1, KDR, MET, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.78363 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS2, TBXAS1 |
6.74126 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP1 |
6.65633 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MTNR1B, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.61599 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP1 |
6.61599 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC |
6.5791 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.57904 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.57904 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, PRKCE, SRC, TNKS, TNKS2, TRPV1 |
6.55409 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS2, TBXAS1 |
6.55116 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.54963 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MTNR1B, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.5156 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IDO1, IGF1R, KDR, MPO, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
6.4491 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, PIM1, PRKCA, PTGS2 |
6.30317 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
6.29459 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC |
6.28098 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
6.26911 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
6.23633 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
6.09109 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, PRKCD, PRKCE, PTGS2, SRC |
5.9654 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
5.94413 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
5.94413 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, KCNA3, MMP12, MTNR1B, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
5.91586 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IDO1, IGF1R, KDR, MET, MMP12, MPO, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
5.90078 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, MPO, PIM1, PPARA, PRKCA, PRKCD, PTGS2, RORC, SIGMAR1, SRC, TNKS2, TYR |
5.89445 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2, PRKCE |
5.87316 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IDO1, IGF1R, KDR, MET, MPO, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.84417 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HTR1A, HTR2B, IDO1, IGF1R, KDR, MAOA, MET, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
5.80803 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
5.74626 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IDO1, IGF1R, KDR, MET, MPO, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.73424 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2 |
5.73051 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.64733 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.59516 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, IDO1, MAOA, MPO |
5.58844 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
5.56028 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, MPO, PPARA, PRKCB, PRKCE, PTGS2, SRC, TRPV1, TYR |
5.51216 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS2, TBXAS1 |
5.48985 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, PRKCD, PTGES, PTGS2, SRC |
5.44543 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, MTNR1B, PRKCB, PRKCE, SRC, TRPV1 |
5.36437 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SRC |
5.26019 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, PRKCD, PRKCE, SRC |
5.26019 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP1 |
5.25143 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, MET, MTNR1B, PRKCB, PRKCE, TRPV1 |
5.21986 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS2, TBXAS1 |
5.21722 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
5.18267 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
5.16855 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IDO1, IGF1R, KDR, MPO, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
5.14492 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HTR1A, MAOA, TYR |
5.14059 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B, SIGMAR1, SRC |
5.14059 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGES, PTGS2, TBXAS1 |
5.10473 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR2A, HTR2B, IDO1, IGF1R, KDR, MET, MMP12, MPO, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
5.09602 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, MTNR1B, PRKCG, PTGS2, TRPV1 |
5.06611 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.03567 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP1 |
5.00865 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, IDO1, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2 |
4.97325 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
4.94245 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, PTGS2, TNKS, TNKS2 |
4.94133 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MTNR1A, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.94133 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MTNR1A, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.94133 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, PRKCE, PTGS2 |
4.94113 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
4.93181 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
4.91396 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
4.91396 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA, PTGES, PTGS2, TBXAS1 |
4.86329 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
4.82909 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
4.82909 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2A, HTR2B, IDO1, KDR, MET, MMP12, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SRC, TNKS2, TRPV1, XDH |
4.82245 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PRKCE, PTGS2 |
4.81041 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PRKCE, PTGS2 |
4.81041 |
[BP] GO:0019371 |
None
|
CBR1, PTGES, PTGS2, TBXAS1 |
4.75733 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, IDO1, MTNR1A, PPARA, PRKCE, PRKCG, PTGS2, TRPV1 |
4.75486 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
4.73946 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2B, IDO1, IGF1R, KDR, MAOA, MET, MMP12, MPO, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
4.73946 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
4.73879 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCA, PRKCB, PRKCD |
4.68893 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, MTNR1A, MTNR1B, PPARA, RORC, TOP1 |
4.61627 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.61627 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
4.61627 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS |
4.61401 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, HCAR2, HTR2A, HTR2B, IDO1, KDR, MET, MMP12, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SRC, TRPV1 |
4.57956 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IDO1, IGF1R, KDR, MET, MMP12, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.57956 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, IDO1, PPARA, PTGES, PTGS2, TBXAS1 |
4.54084 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
4.50888 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
4.48738 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
4.48738 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A, TRPV1 |
4.48738 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7, PRKCE |
4.47506 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
4.45374 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
4.40878 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.40359 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
4.38123 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.37092 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.37092 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
4.36856 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
4.35458 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HTR1A, HTR2B, IDO1, IGF1R, KDR, MAOA, MET, MMP12, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
4.33494 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
4.30649 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
4.30649 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.30649 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
4.30649 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MTNR1A, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.28422 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MTNR1A, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.22537 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, HTR1A, HTR2A, KCNA3, PRKCD, PRKCE, PTGS2 |
4.21606 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.19556 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CHRM1, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
4.1642 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HTR5A, KDR, PIM1, PPARA, PTGS2, RORC, SIGMAR1, SRC, TYR |
4.16317 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3, PRKCE |
4.15019 |
[BP] GO:0030168 |
platelet activation
|
AXL, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.15019 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2 |
4.13458 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
4.11202 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
4.09447 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
4.08942 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, DRD3, HSD11B2, HTR2A, IDO1, MMP12, MPO, PRKCD, PTGES, PTGS2, SRC, TRPV1, TYR |
4.08504 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
4.07442 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PRKCD, PRKCE, PTGS2 |
4.06475 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PRKCD, SRC |
4.04192 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.03927 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, MTNR1B, PRKCA, PRKCE, SRC, TRPV1 |
4.02727 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PPARA, PRKCD, PTGS2, RORC, SRC, TNKS, TNKS2, TRPV1 |
4.01739 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MAOA, MET, MMP12, MPO, MTNR1A, MTNR1B, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
3.99303 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.98054 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, TRPV1 |
3.97727 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
3.95411 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.95136 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PRKCE, SRC, TRPV1 |
3.94225 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MAOA, MET, MMP12, MPO, MTNR1A, MTNR1B, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TOP1, TRPV1, XDH |
3.93729 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.92872 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
3.91691 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, PRKCD, SRC, TYR |
3.90568 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.87353 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.87353 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.87353 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.8516 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.84362 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.79225 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.7902 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.7902 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.7902 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.7902 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.78939 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, DRD2, F10, F3, MET, PRKCA, PRKCD, PRKCE, XDH |
3.78418 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.75681 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.74574 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
3.74574 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, MTNR1B, PRKCA, PRKCE, SRC |
3.72803 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B, PRKCE |
3.71503 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, PTGS2, TRPV1 |
3.70452 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, IDO1, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
3.70335 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F10, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
3.70143 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.69189 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.67045 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MET, MMP12, MTNR1A, PPARA, PRKCD, PTGS2, RORC, SRC, TNKS, TNKS2, TRPV1 |
3.63663 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, MTNR1B, PRKCG |
3.6251 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.62469 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, MTNR1B, PRKCA, PRKCE |
3.60856 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
3.60746 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCE, PTPN1, SRC, XDH |
3.58639 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
3.57835 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, IGF1R, MET, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.54027 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A, PRKCE, PTGS2 |
3.54027 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.52981 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, DRD2, DRD3, HCAR2, HTR2A, PRKCA, PTGS2, TRPV1 |
3.52732 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PPARA, PRKCD, PRKCE |
3.51871 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.51514 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B, PRKCE |
3.50801 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
3.507 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.50626 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MPO |
3.50626 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CHRM1, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.50619 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SRC, TRPV1 |
3.48861 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNA3, PPARA, PRKCB, PRKCE, TRPV1 |
3.45653 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGES, PTGS2, SRC |
3.45653 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, IDO1, PRKCG |
3.45448 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.44437 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.43902 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, IDO1, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
3.4359 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
3.43405 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.43257 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC, TOP1 |
3.42409 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.42235 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.42235 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, HSD11B2, PPARA, PTGS2 |
3.4186 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F10, F3, MET, SRC, XDH |
3.41758 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, PRKCG, RORC |
3.38982 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TRPV1, XDH |
3.38687 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.35747 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCE, SRC |
3.35725 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, IDO1, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
3.35681 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
3.35538 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, IDO1, IGF1R, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.33825 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, IDO1, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
3.32564 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
3.31206 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
3.30904 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.29814 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
3.29791 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.2898 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.27525 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.27474 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, MPO, PTGES, PTGS2, SRC |
3.26634 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, BCL2, CDK6, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
3.24914 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
3.21387 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
3.21387 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, PRKCD, SRC |
3.17978 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CYP1A1, HTR2A, MPO, PRKCD, PTGS2 |
3.16742 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1, ESR1 |
3.16742 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.15599 |
[BP] GO:0051223 |
None
|
ACHE, CHRM1, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.14795 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PRKCD, PTGS2 |
3.14583 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.14166 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.14166 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, MTNR1A, PPARA, PRKCA |
3.13675 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CHRM1, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, PRKCG, PTGS2, SRC, TRPV1, TYR |
3.13454 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, PTGS2 |
3.1209 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
3.11528 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, F10, F3, IGF1R, KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
3.09163 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, PRKCE, TRPV1 |
3.08767 |
[BP] GO:0043278 |
None
|
DRD2, DRD3, PRKCE, PRKCG |
3.07307 |
[BP] GO:0014072 |
None
|
DRD2, DRD3, PRKCE, PRKCG |
3.07307 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, NQO2, RORC |
3.06979 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, BCL2, CHRM1, CSNK2A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
3.06823 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
3.06823 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, ESRRB, HTR2A, MTNR1A, PPARA, PRKCA |
3.06011 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, ESRRB, HCAR2, HTR2A, HTR2B, KDR, MET, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
3.05148 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, PRKCE, SRC |
3.04189 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3, PRKCE |
3.04189 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.03299 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.03299 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PRKCD, PTGES, PTGS2, SRC |
3.02249 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, PRKCE, TRPV1 |
2.98333 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
2.9609 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.93664 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, XDH |
2.92954 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MET, MMP12, MTNR1A, PPARA, PRKCD, PRKCG, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.90982 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, BCL2, CHRM1, DRD2, HCAR2, HTR2B, MMP12, PRKCD, PRKCE, PTGS2, SRC |
2.90982 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HTR2B, MMP12, PRKCE, SRC |
2.90901 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.90638 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.90638 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.90327 |
[BP] GO:0050708 |
None
|
ACHE, DRD2, DRD3, HCAR2, HTR2B, MMP12, MTNR1B, PRKCA, PRKCE, SRC |
2.89488 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.89155 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, PRKCA, PRKCE, PTGS2, SRC |
2.88261 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP1, TRPV1, XDH |
2.86947 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.86542 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.85169 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PRKCD, PTGES, PTGS2, SRC |
2.84954 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
2.84461 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, MPO, PTGS2, SRC, TRPV1, TYR |
2.83639 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.83639 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.83639 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
2.82423 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.78737 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HTR2B, IGF1R, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.78015 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.75931 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, PRKCA, SRC |
2.75052 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.74365 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.74365 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.74365 |
[BP] GO:0050890 |
None
|
ADORA1, CHRM1, DRD1, DRD2, DRD3, HTR2A, PRKCG, PTGS2 |
2.74232 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, PRKCA, PTPN1, SRC |
2.72157 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
2.72157 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGES, PTGS2 |
2.66743 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.66657 |
[BP] GO:0050965 |
None
|
ADORA1, HTR2A, TRPV1 |
2.65962 |
[BP] GO:0050961 |
None
|
ADORA1, HTR2A, TRPV1 |
2.65962 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.65962 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, ESR1, HTR2A, HTR2B, PRKCE, TRPV1 |
2.61227 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, DRD2, HTR2A, PTGS2 |
2.61227 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.57871 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.57871 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57871 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, PRKCE, PRKCG |
2.57234 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
2.56307 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, GBA2, IDO1, MAOA, MMP12, MPO, SRC, XDH |
2.56195 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, IGF1R, PRKCD, PRKCG, SRC, TNKS, TNKS2 |
2.56195 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, ESR1, FABP4, IDO1, MMP12, PPARA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
2.56074 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.55427 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
2.55236 |
[BP] GO:0043279 |
None
|
DRD2, DRD3, PRKCE, PRKCG, TRPV1 |
2.51232 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.51232 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.51 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.51 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTGS2, SRC |
2.49679 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.49679 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.49679 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49679 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, CHRM1, DRD2, HCAR2, HTR2B, MMP12, PRKCD, PRKCE, PTGS2, SRC |
2.49679 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.44391 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.44391 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2 |
2.44167 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.44011 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.44011 |
[BP] GO:0051100 |
negative regulation of binding
|
AURKB, CYP2D6, MET, PPARA, PRKCD, TNKS |
2.43127 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTGS2, SRC |
2.43127 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, BCL2, CDK6, CYP1B1, DRD2, FABP3, IDO1, PTGES, PTGS2, XDH |
2.4267 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MET, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TNKS, XDH |
2.39874 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.38205 |
[BP] GO:0016048 |
None
|
ADORA1, HTR2A, TRPV1 |
2.38205 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.38205 |
[BP] GO:0050730 |
None
|
ADORA1, FLT3, HTR2A, PRKCD, PRKCE, PTPN1, SRC |
2.37404 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.36214 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, HSD11B2, MPO, PTGS2, SRC, TRPV1, TYR |
2.35596 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PRKCE, SRC |
2.35042 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.3482 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.34355 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.34355 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
2.33551 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, HCAR2, HTR2B, MMP12, PRKCE, SRC |
2.33551 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.32781 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
2.32781 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.32781 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, MPO, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
2.32781 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, PTGES, PTGS2 |
2.32752 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MPO |
2.31931 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, PRKCE, PTGES, PTGS2, SRC |
2.30134 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MET, MMP12, MPO, MTNR1A, MTNR1B, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TOP1, TRPV1, XDH |
2.2905 |
[BP] GO:0006816 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B, PRKCB, PRKCE, TRPV1 |
2.27815 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.27212 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.27212 |
[BP] GO:0032094 |
None
|
CYP1A1, HSD11B2, MPO |
2.27212 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.27212 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.27212 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, PRKCD, PTGS2, TRPV1, XDH |
2.25501 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2432 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.2432 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2432 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.23451 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, PRKCD |
2.23273 |
[BP] GO:0072347 |
None
|
DRD2, DRD3, PRKCE, PRKCG |
2.22213 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22018 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.22018 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, PRKCD, SRC |
2.22018 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KDR, MET, MMP12, MPO, MTNR1A, MTNR1B, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
2.21032 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, HTR2A, PPARA, PRKCE, RORC, SRC |
2.19893 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, PRKCD, SRC |
2.19893 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, AXL, BCL2, CA2, CDK6, CYP19A1, DRD2, ESR1, ESRRA, HCAR2, IDO1, MMP12, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.19564 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2 |
2.18719 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.1868 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.17479 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.17479 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.1731 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.1731 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.1731 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.1731 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, IGF1R, PRKCD, PTPN1, SRC |
2.16898 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.15363 |
[BP] GO:0019229 |
None
|
ADRA1A, CHRM1, HTR2A, PTGS2 |
2.15363 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, MPO, PRKCD, PTGS2, SRC |
2.14742 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, CYP2D6, MET, PPARA, PRKCD, SRC, TNKS |
2.14742 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.14647 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.13177 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2D6, MAOA, MPO |
2.13177 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.12735 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.10627 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, PRKCD, PRKCE, PTPN1, SRC, TNKS, XDH |
2.09427 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, HCAR2, HTR2B, MET, PPARA, PRKCG |
2.08477 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.07776 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD1, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TNKS, TNKS2, TOP1 |
2.07584 |
[BP] GO:0036211 |
protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD1, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TNKS, TNKS2, TOP1 |
2.07584 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.06769 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.06769 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.06769 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.06769 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.06769 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.06769 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.06769 |
[BP] GO:0071502 |
None
|
HTR2B, TRPV1 |
2.06769 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.06769 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.06769 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.06769 |
[BP] GO:0010959 |
None
|
ADORA1, BCL2, DRD1, DRD2, DRD3, HTR2A, PRKCE, PTGS2 |
2.06769 |
[BP] GO:0030802 |
None
|
DRD1, DRD2, DRD3, MTNR1A, PRKCA |
2.06337 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MAOA, MET, MMP12, MPO, MTNR1A, MTNR1B, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
2.06337 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, PRKCE, SRC |
2.06196 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.04401 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.04401 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP12, MTNR1A, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.04335 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CHRM4, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
2.04303 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SRC, TRPV1 |
2.04069 |
[BP] GO:0010675 |
None
|
ESRRB, PPARA, PRKCE, RORC, SRC |
2.03766 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, DRD3, TNKS2 |
2.00413 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.00413 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.00348 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.00348 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, IDO1, MPO, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, SRC, TRPV1 |
2.0014 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1, TRPV1 |
7.20683 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MAOA, MET, MTNR1A, MTNR1B, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR |
6.84926 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, GBA2, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MET, MTNR1A, MTNR1B, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TRPV1 |
6.00578 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1, TRPV1 |
5.73984 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F10, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MET, MTNR1A, MTNR1B, PRKCG, PTGS2, SIGMAR1, SRC, TRPV1 |
5.43378 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MAOA, MET, MTNR1A, MTNR1B, PRKCG, PTGES, PTGS2, PTPN1, SIGMAR1, SRC, TBXAS1, TRPV1, TYR |
5.06702 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, HTR2A, MET, PRKCG, PTGS2, SIGMAR1, SRC, TRPV1 |
3.84804 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MAOA, MET, MMP12, MPO, MTNR1A, MTNR1B, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
3.57562 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GBA2, HTR5A, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SIGMAR1, XDH |
3.46718 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, F10, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
3.21953 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, HTR5A, IDO1, KDR, MAOA, MPO, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
3.08767 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, PTGS2, SIGMAR1, TBXAS1 |
3.03313 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, PTGS2, PTPN1, SIGMAR1, TBXAS1 |
3.01119 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNA3, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
2.43127 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.32781 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, KCNA3, PRKCG, PTGS2, SRC |
2.20894 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, CA4, PRKCA, PRKCD, PRKCE, PRKCG, PTGES, SRC, TNKS2, TYR |
2.15895 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, KCNA3, PRKCG, PTGS2, SRC |
2.02415 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, DRD2, HTR2A, HTR2B, HTR5A, KCNA3, PRKCG, PTGS2, SRC |
2.02256 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP12, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TBXAS1, TNKS, TYR, XDH |
11.7748 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
11.3296 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP12, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
11.3296 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, SIGMAR1, TRPV1 |
11.2868 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CDK6, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, SIGMAR1, TRPV1 |
10.3997 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, RORC, SIGMAR1, TRPV1 |
10.0519 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.0025 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.0025 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, PRKCE, RORC, SIGMAR1, TRPV1 |
9.81863 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SIGMAR1, SRC, TOP1, TRPV1 |
9.74128 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.72019 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, MMP12, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
9.32174 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, MAOA, MPO, NQO2, PTGS2, TBXAS1, TYR, XDH |
9.1418 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOA, MET, MMP12, MPO, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TYR, XDH |
8.88402 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1, TRPV1 |
7.81769 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MTNR1A, MTNR1B, SIGMAR1, TRPV1 |
7.81769 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.63512 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, IDO1, MPO, PTGS2, SRC, TBXAS1 |
6.92926 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B2, HSD17B1, IDO1, MPO, NQO2, PTGES, PTGS2, SRC, TBXAS1, XDH |
6.81396 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, IDO1, MPO, PTGS2, SRC, TBXAS1 |
6.66573 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.61599 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.61599 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.57904 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.57904 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP12, NQO2, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS |
6.14602 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.91649 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
5.80803 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, MTNR1A, MTNR1B, SIGMAR1 |
5.72673 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.65389 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
5.22811 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, XDH |
5.11931 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.10375 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.05928 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.89353 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.89353 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MMP12, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.84609 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.82909 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
4.77005 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.76445 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
4.51197 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.4812 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.37092 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
4.33881 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGS2, TBXAS1, TYR |
4.25054 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
4.19556 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP12, MPO, MTNR1A, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TBXAS1, TOP1, TRPV1, XDH |
4.09009 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.03927 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.95454 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
3.91297 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.7902 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC, TRPV1 |
3.76556 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.33035 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.21953 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.20554 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1 |
3.14166 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.03299 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.94788 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.92192 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.92192 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
2.90982 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.90638 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.90638 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.90638 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.83639 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.77241 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, CSNK2A1, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TOP1 |
2.67904 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, KDR, MET, MMP12, MPO, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TBXAS1, TOP1, TRPV1, XDH |
2.67301 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, MTNR1A, NQO2 |
2.63705 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.59366 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, TRPV1, XDH |
2.515 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.51 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.49679 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.49679 |
[MF] GO:0043168 |
anion binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, F10, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MPO, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, SRC, TOP1, TRPV1, XDH |
2.45101 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.44391 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.32781 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2432 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, TRPV1, XDH |
2.13804 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP1, TRPV1, XDH |
2.1373 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.06769 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, KCNA3, KDR, MAOA, MET, MMP12, MPO, MTNR1A, MTNR1B, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGES, PTGS2, PTPN1, RORC, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TOP1, TRPV1, TYR, XDH |
2.05863 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.04401 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.00348 |